MaltSci 麦伴科研

Appearance

Popular Reports / hematology

This report is written by MaltSci based on the latest literature and research findings

What is the role of stem cells in hematopoiesis? ​

Abstract ​

Hematopoiesis, the process of blood cell formation, is fundamentally reliant on hematopoietic stem cells (HSCs), which possess the unique abilities to self-renew and differentiate into all blood cell lineages. This review synthesizes current knowledge regarding the multifaceted role of HSCs in hematopoiesis, emphasizing their significance in maintaining blood homeostasis and their involvement in various hematological disorders. HSCs originate from distinct embryonic sources, including the yolk sac and aorta-gonads-mesonephros (AGM) region, and reside within specialized niches in the bone marrow that provide critical regulatory signals. The differentiation pathways of HSCs lead to the formation of myeloid and lymphoid lineages, each governed by intricate molecular mechanisms involving transcription factors and signaling pathways. Notably, the dysregulation of HSC function can result in hematological malignancies such as leukemia, where leukemic stem cells (LSCs) emerge, posing challenges for treatment. Advances in stem cell research, particularly the development of induced pluripotent stem cells (iPSCs) and gene editing technologies, present new opportunities for therapeutic interventions. This review highlights the need for ongoing research to deepen our understanding of HSC biology and to translate these findings into effective clinical strategies for blood-related diseases.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Hematopoietic Stem Cells (HSCs)
    • 2.1 Definition and Characteristics of HSCs
    • 2.2 Sources of HSCs
  • 3 Differentiation Pathways in Hematopoiesis
    • 3.1 Myeloid Lineage Differentiation
    • 3.2 Lymphoid Lineage Differentiation
  • 4 Molecular Mechanisms Regulating Hematopoiesis
    • 4.1 Transcription Factors Involved
    • 4.2 Signaling Pathways and Cytokines
  • 5 Stem Cells in Hematological Disorders
    • 5.1 Role of Stem Cells in Leukemia
    • 5.2 Stem Cell Transplantation in Blood Disorders
  • 6 Advances in Stem Cell Research
    • 6.1 Induced Pluripotent Stem Cells (iPSCs)
    • 6.2 Gene Editing Technologies
  • 7 Conclusion

1 Introduction ​

Hematopoiesis, the intricate process of blood cell formation, is a vital biological function that ensures the maintenance of homeostasis within the human body. This process is primarily governed by hematopoietic stem cells (HSCs), which possess the unique ability to self-renew and differentiate into various blood cell lineages, including red blood cells, white blood cells, and platelets. Understanding the role of stem cells in hematopoiesis is not only crucial for comprehending normal physiological processes but also for elucidating the pathophysiology of various hematological disorders. This review aims to synthesize current knowledge regarding the multifaceted role of stem cells in hematopoiesis, highlighting their significance in both health and disease.

The importance of HSCs in hematopoiesis has been well established, as they serve as the foundational precursors for all blood cells throughout an individual's life [1]. Recent advances in stem cell research have underscored the complexities of HSC biology, including their niche interactions, differentiation pathways, and regulatory mechanisms. Furthermore, the exploration of stem cell roles in hematological disorders, such as leukemia and aplastic anemia, has revealed potential therapeutic strategies, including stem cell transplantation and gene editing techniques [2][3].

Currently, the field of hematopoiesis research is experiencing rapid growth, driven by technological advancements that allow for a deeper understanding of stem cell dynamics. For instance, studies utilizing zebrafish models have provided insights into the embryonic origins of HSCs and their interactions with the microenvironment [2]. Additionally, the identification of key transcription factors and signaling pathways that regulate HSC function has opened new avenues for therapeutic interventions [4][5].

The organization of this review is structured to comprehensively cover the various aspects of stem cells in hematopoiesis. We will begin by defining HSCs and discussing their characteristics and sources. Subsequently, we will explore the differentiation pathways in hematopoiesis, focusing on both myeloid and lymphoid lineages. Following this, we will delve into the molecular mechanisms that regulate hematopoiesis, including the roles of transcription factors and cytokine signaling pathways. The review will also address the implications of stem cells in hematological disorders, emphasizing their roles in leukemia and the potential of stem cell transplantation as a treatment strategy. Furthermore, we will highlight recent advancements in stem cell research, particularly the emergence of induced pluripotent stem cells (iPSCs) and gene editing technologies that promise to revolutionize therapeutic approaches to blood-related diseases. Finally, we will conclude with a discussion on the future directions of research in this field, emphasizing the importance of continued exploration of stem cell biology to inform clinical practices.

In summary, the role of stem cells in hematopoiesis is multifaceted and critically important for both understanding normal blood formation and addressing hematological diseases. By synthesizing current research findings and identifying gaps in knowledge, this review aims to provide a comprehensive overview of the pivotal role of stem cells in hematopoiesis, setting the stage for future research and therapeutic advancements.

2 Hematopoietic Stem Cells (HSCs) ​

2.1 Definition and Characteristics of HSCs ​

Hematopoietic stem cells (HSCs) are a specialized class of multipotent stem cells that reside primarily in the bone marrow and are crucial for the lifelong maintenance of blood cell production. These cells possess unique characteristics that enable them to generate all types of blood cells, including red blood cells, white blood cells, and platelets, through a process known as hematopoiesis. HSCs are defined by their ability to self-renew, which allows them to maintain their population over an individual's lifetime, and their capacity to differentiate into various lineage-specific progenitor cells.

The developmental origins of HSCs are complex and have been a subject of extensive research. During embryogenesis, HSCs arise from the vascular endothelium, particularly in the aorta-gonads-mesonephros (AGM) region, as well as from the yolk sac, which contributes to early hematopoiesis by producing primitive erythrocytes [6]. The emergence of HSCs in the AGM region marks a transition to the generation of definitive hematopoietic stem cells that can give rise to all adult blood cell types [3].

HSCs exhibit a hierarchical organization, with a well-defined lineage commitment leading to myeloid and lymphoid progenitors. The differentiation process is regulated by various intrinsic and extrinsic factors, including signaling pathways, transcription factors, and the microenvironment in which HSCs reside [7]. For instance, the Notch signaling pathway plays a pivotal role in the development and maintenance of HSCs and their progenitors, particularly in the lymphoid lineage [8].

The microenvironment, or niche, surrounding HSCs is also critical for their function and regulation. This niche comprises various cell types and extracellular matrix components that provide the necessary signals for HSC maintenance, self-renewal, and differentiation [9]. Recent studies have emphasized the importance of metabolic regulation within HSCs, highlighting how mitochondrial function and energy metabolism influence their fate decisions [10].

In summary, HSCs are fundamental to hematopoiesis due to their unique properties of self-renewal and multipotency, their complex developmental origins, and their interaction with the specialized microenvironment that regulates their behavior. Understanding the biology of HSCs not only sheds light on normal hematopoiesis but also has significant implications for therapeutic strategies in treating hematological disorders and improving stem cell transplantation outcomes.

2.2 Sources of HSCs ​

Hematopoietic stem cells (HSCs) are pivotal in the process of hematopoiesis, which is the formation of blood cells. These multipotent stem cells have the unique capability to differentiate into all types of blood cells, including red blood cells, white blood cells, and platelets, thereby playing a critical role in maintaining the homeostasis of the blood system throughout an individual's life.

HSCs originate from specific anatomical sites during embryonic development. Research has identified two primary sources of hematopoietic cells: the yolk sac and the aorta-gonads-mesonephros (AGM) region. The yolk sac is responsible for the first wave of hematopoiesis, producing primitive erythrocytes, while the AGM region is where adult-type HSCs emerge, capable of sustaining lifelong hematopoiesis [6].

The development of HSCs is a complex process influenced by various signaling pathways and microenvironments. The Notch signaling pathway, for example, is essential for the emergence of definitive HSCs during embryonic development and plays a role in maintaining HSC homeostasis in the bone marrow [8]. Additionally, the transition of HSCs from the dorsal aorta to the fetal liver is regulated by factors such as microRNAs, specifically the let-7 family, which modulates signaling pathways crucial for this niche transition [11].

Moreover, HSCs reside within a specialized microenvironment known as the HSC niche, primarily located in the bone marrow. This niche comprises various cell types that interact with HSCs to regulate their self-renewal and differentiation [9]. The intricate relationships within the niche ensure that HSCs can respond to physiological demands, such as increased blood cell production during stress or injury.

In summary, HSCs are fundamental to hematopoiesis, originating from distinct embryonic sites and functioning within a supportive niche that regulates their behavior. Understanding the sources and regulatory mechanisms of HSCs is crucial for advancing therapeutic strategies in treating hematological disorders and improving stem cell transplantation outcomes [3].

3 Differentiation Pathways in Hematopoiesis ​

3.1 Myeloid Lineage Differentiation ​

Hematopoiesis is a complex biological process in which hematopoietic stem cells (HSCs) give rise to all blood cell lineages, including the myeloid lineage. HSCs possess the unique ability to self-renew and differentiate into various progenitor cells, which ultimately leads to the formation of mature blood cells. The differentiation pathways in hematopoiesis are tightly regulated and involve multiple stages of lineage commitment.

HSCs are multipotent stem cells located in the bone marrow, capable of differentiating into both myeloid and lymphoid lineages. The myeloid lineage encompasses a variety of cell types, including granulocytes, monocytes, macrophages, and dendritic cells. During hematopoiesis, the first major branching point occurs when HSCs differentiate into common myeloid progenitors (CMPs) and common lymphoid progenitors (CLPs). This decision is influenced by intrinsic factors, such as transcription factors, and extrinsic factors from the bone marrow microenvironment, which plays a crucial role in regulating self-renewal, survival, and differentiation of HSCs[12].

Recent studies have elucidated the mechanisms underlying myeloid differentiation. For instance, the expression of cell adhesion molecules like JAM-C is critical for defining HSCs and controlling myeloid progenitor generation. JAM-C is highly expressed on HSCs, particularly on long-term repopulating HSCs, and its expression decreases with differentiation. In Jam-C-deficient mice, there is an observed increase in myeloid progenitors and granulocytes, indicating that JAM-C is essential for regulating the balance between self-renewal and differentiation within the myeloid lineage[13].

Additionally, epigenetic mechanisms, such as DNA methylation, have been shown to play a significant role in the lineage commitment of HSCs. Changes in DNA methylation profiles during hematopoiesis influence the division of stem cells into myeloid and lymphoid lineages and contribute to the establishment of specific phenotypes and functionalities in differentiated cells[7].

Moreover, the myeloid lineage is characterized by a hierarchical differentiation process, where HSCs give rise to increasingly committed progenitor cells. This process involves a series of lineage restriction steps that progressively limit the differentiation potential of progenitor cells. The common myeloid progenitor (CMP) can further differentiate into granulocyte-monocyte progenitors (GMPs) and megakaryocyte-erythroid progenitors (MEPs), which subsequently give rise to specific myeloid cell types[14].

Understanding the differentiation pathways in myeloid lineage development is critical for addressing hematologic disorders, as defects in myelopoiesis can lead to various diseases, including leukemias. For example, acute myeloid leukemia (AML) is characterized by the accumulation of immature myeloid blast cells, resulting from a combination of genetic mutations that disrupt normal differentiation processes[15].

In summary, stem cells play a pivotal role in hematopoiesis by serving as the foundational source for all blood cell lineages, particularly within the myeloid lineage. Their differentiation is influenced by a complex interplay of intrinsic and extrinsic factors, which regulate the balance between self-renewal and lineage commitment. Understanding these pathways not only enhances our knowledge of normal hematopoiesis but also informs the development of therapeutic strategies for hematologic malignancies.

3.2 Lymphoid Lineage Differentiation ​

Hematopoiesis is a complex process through which hematopoietic stem cells (HSCs) give rise to various blood cell lineages, including lymphoid and myeloid cells. The differentiation of HSCs into these lineages is tightly regulated and occurs through a series of well-defined pathways.

Hematopoietic stem cells are multipotent cells residing primarily in the bone marrow, capable of self-renewal and differentiation into all blood cell types. The earliest lineage decisions made by blood progenitor cells involve choosing between lymphoid and myeloid fates. The commitment to either lineage is a critical step in hematopoiesis, significantly influencing the types of immune cells produced and their functional roles in the immune system.

One of the key factors in lymphoid lineage commitment is myocyte enhancer factor 2C (MEF2C), which has been shown to be indispensable for the lymphoid fate decision. MEF2C works in concert with early B cell factor-1 (EBF1) as a co-regulator of gene expression, targeting a subset of B cell-specific genes. The activation of MEF2C is mediated by the p38 MAPK pathway, which drives B cell differentiation. In studies involving Mef2c knockout mice, it was observed that there was a reduction in B lymphoid-specific gene expression and an increase in myeloid gene expression, indicating the pivotal role of MEF2C in maintaining the lymphoid lineage commitment [16].

Further insights into the differentiation pathways reveal that during embryogenesis, lymphoid cells develop from progenitor populations that predate the emergence of HSCs. This indicates that the ontogeny of lymphoid cells is complex, involving multiple stages and cell types, including T cells, B cells, and innate lymphoid cells (ILCs). Recent advances in single-cell RNA sequencing and pluripotent stem cell models have provided new perspectives on lymphoid development, enabling the generation of lymphoid immune cells independent of HSCs [17].

Additionally, the differentiation of HSCs into lymphoid and myeloid lineages is influenced by the bone marrow microenvironment and the presence of specific transcription factors. The process is characterized by a hierarchical structure where multipotent progenitors gradually lose their differentiation potential, culminating in the formation of lineage-restricted progenitors. This stepwise restriction is essential for the proper functioning of the immune system, as it ensures a diverse repertoire of immune cells capable of responding to various pathogens [18].

The understanding of lymphoid lineage differentiation is further enriched by identifying the transcriptional regulatory networks that orchestrate these processes. The interactions between different transcription factors and their regulatory elements dictate the fate decisions of HSCs, ultimately influencing the development of key immune cells such as B cells and T cells [19].

In summary, stem cells play a crucial role in hematopoiesis by serving as the foundation for the differentiation of lymphoid cells. The regulatory mechanisms governing this process involve a complex interplay of transcription factors, signaling pathways, and the bone marrow microenvironment, which collectively shape the immune landscape.

4 Molecular Mechanisms Regulating Hematopoiesis ​

4.1 Transcription Factors Involved ​

Hematopoiesis, the process by which all blood cells are formed, is critically dependent on hematopoietic stem cells (HSCs). These cells possess the unique ability to self-renew and differentiate into various blood lineages, thereby maintaining the balance of blood cell production necessary for homeostasis and immune function. The regulation of hematopoiesis involves a complex interplay of molecular mechanisms, including transcription factors that play pivotal roles in lineage specification and differentiation.

Transcription factors are essential for HSC function as they orchestrate the gene expression programs that dictate cell fate decisions. These factors can either promote self-renewal or induce differentiation, and their activity is finely tuned by various signaling pathways and the microenvironment provided by the HSC niche. For instance, the role of transcription factors in lineage programming is underscored by their ability to activate or repress specific gene sets that are critical for the development of particular blood cell types.

Recent studies have highlighted several key transcription factors involved in the regulation of hematopoiesis. For example, the transcription factor RUNX1 is crucial for the early stages of hematopoietic development and is involved in the specification of HSCs from mesodermal progenitors during embryogenesis. Similarly, the transcription factor PU.1 is essential for myeloid and lymphoid lineage commitment, guiding HSCs toward specific blood cell fates.

Additionally, transcription factors such as GATA-1 and GATA-2 are vital for erythropoiesis and megakaryocyte development, respectively. They function by binding to regulatory regions of target genes, thereby modulating the transcriptional landscape necessary for the proper development of these lineages. The interplay between these transcription factors and the epigenetic landscape also plays a significant role in determining HSC fate. Epigenetic modifiers can influence the accessibility of chromatin to transcription factors, thus impacting gene expression and the ability of HSCs to respond to differentiation cues.

Moreover, the regulatory networks involving transcription factors are influenced by extrinsic signals from the HSC niche, which provides the necessary cues for maintaining HSC quiescence and self-renewal. Factors such as cytokines and growth factors produced by niche cells interact with HSCs, further modulating the activity of transcription factors and thus influencing their behavior in response to physiological demands.

In summary, transcription factors are central to the regulation of hematopoiesis, governing the balance between self-renewal and differentiation of HSCs. Understanding the precise roles and regulatory mechanisms of these factors is crucial for elucidating the complexities of hematopoietic development and may provide insights into therapeutic strategies for blood disorders and leukemias [20][21][22].

4.2 Signaling Pathways and Cytokines ​

Hematopoiesis is the physiological process through which hematopoietic stem cells (HSCs) generate all types of blood cells, a critical function for maintaining the blood system and ensuring immune response and homeostasis in mammals. HSCs are unique in their ability to self-renew and differentiate into various blood lineages, which is essential for sustaining hematopoiesis throughout the life of an organism. The regulation of hematopoiesis involves a complex interplay of molecular mechanisms, signaling pathways, and cytokines.

HSCs reside in specialized microenvironments known as niches within the bone marrow, where they receive extrinsic signals that regulate their behavior. The stem cell niche provides essential support for maintaining HSC quiescence, self-renewal, and differentiation. This microenvironment consists of various cellular components, including stromal cells, endothelial cells, and other hematopoietic cells, which collectively contribute to the signaling pathways that guide HSC fate decisions [20].

Cytokines play a pivotal role in hematopoiesis by influencing the proliferation and differentiation of HSCs and their progeny. For instance, interleukin-3 (IL-3), interleukin-6 (IL-6), and stem cell factor (SCF) are critical cytokines that promote the survival and expansion of HSCs and progenitor cells. These cytokines bind to specific receptors on HSCs, triggering intracellular signaling cascades that result in the activation of transcription factors essential for lineage commitment and differentiation [21].

In addition to cytokines, signaling pathways such as the Notch, Wnt, and Hedgehog pathways are crucial in regulating hematopoiesis. The Notch signaling pathway, for example, is involved in maintaining HSC self-renewal and preventing premature differentiation. Activation of Notch signaling in HSCs leads to the expression of target genes that promote stem cell characteristics and inhibit differentiation into mature blood cells [5]. Similarly, Wnt signaling is essential for HSC maintenance and is thought to regulate the balance between self-renewal and differentiation by modulating the expression of key transcription factors [23].

Epigenetic modifications also play a significant role in the regulation of HSC function and hematopoiesis. These modifications can alter gene expression patterns in response to intrinsic and extrinsic signals, thus influencing HSC fate decisions. For instance, the activity of various epigenetic regulators, such as histone modifiers and DNA methyltransferases, is critical for maintaining HSC identity and facilitating their differentiation into specific blood lineages [24].

Furthermore, the metabolic state of HSCs is intricately linked to their function. Recent studies have shown that lipid metabolism significantly influences HSC activity, affecting their self-renewal and differentiation capabilities. HSCs rely on specific metabolic pathways to maintain their quiescent state and respond effectively to signals from their niche [25].

In summary, the role of stem cells in hematopoiesis is multifaceted and regulated by a network of molecular mechanisms, signaling pathways, and cytokines. These elements work in concert to ensure that HSCs maintain their self-renewal capacity while also allowing for the differentiation into various blood cell lineages, which is essential for the proper functioning of the immune system and overall hematopoietic homeostasis. Understanding these regulatory mechanisms provides valuable insights into potential therapeutic targets for treating hematological disorders and enhancing stem cell-based therapies.

5 Stem Cells in Hematological Disorders ​

5.1 Role of Stem Cells in Leukemia ​

Hematopoiesis is a complex and tightly regulated process through which hematopoietic stem cells (HSCs) generate all mature blood cells. These stem cells are characterized by their unique abilities to self-renew and differentiate into various progenitor cells that ultimately give rise to different lineages of blood cells. The role of stem cells in hematopoiesis is critical not only for normal physiological functions but also in the context of hematological disorders such as leukemia.

HSCs are multipotent cells that reside in a specialized microenvironment known as the HSC niche, primarily located in the bone marrow. This niche provides essential signals that regulate HSC survival, self-renewal, and differentiation. The disruption of normal hematopoiesis can lead to the development of blood cancers, including leukemia, where the hierarchical organization of hematopoiesis is altered, resulting in uncontrolled proliferation and differentiation block in specific lineages (myeloid or lymphoid) [26].

In the context of leukemia, leukemic stem cells (LSCs) emerge as a subpopulation of malignant cells that retain many characteristics of normal HSCs. These LSCs possess enhanced self-renewal capabilities and are responsible for the initiation and maintenance of the disease [27]. The presence of LSCs poses significant challenges for treatment, as they often exhibit resistance to conventional therapies, which can target more differentiated cancer cells but may leave the LSC population intact [28].

Research has indicated that the molecular mechanisms regulating LSCs share similarities with those governing normal HSC function. For instance, microRNAs (miRNAs) have been identified as crucial regulators of both HSC and LSC biology, influencing pathways related to self-renewal and differentiation. Dysregulation of specific miRNAs in LSCs has been linked to the pathogenesis of acute myeloid leukemia (AML), highlighting the potential for targeting these molecular pathways in therapeutic strategies [29].

Moreover, LSCs occupy the same niches as normal HSCs, which are populated by various supportive cell types that contribute to the niche's functionality. However, in leukemia, the niche is often infiltrated by activated immune cells that can further complicate the interaction dynamics between LSCs and their microenvironment [28]. Understanding these interactions is vital for developing new treatment modalities that can effectively target LSCs while preserving normal hematopoiesis.

In summary, stem cells play a pivotal role in hematopoiesis by providing the foundational elements for blood cell formation and maintaining homeostasis. In leukemia, the dysregulation of these stem cell properties leads to the emergence of LSCs, which are critical for disease initiation and progression. Ongoing research into the molecular and cellular characteristics of LSCs, as well as their interactions with the bone marrow microenvironment, will be essential for advancing therapeutic strategies aimed at effectively treating leukemia and improving patient outcomes [30].

5.2 Stem Cell Transplantation in Blood Disorders ​

Hematopoietic stem cells (HSCs) play a crucial role in hematopoiesis, the process of blood cell formation, which is vital for maintaining the immune system, homeostasis, and responding to inflammatory conditions. HSCs are unique multipotent cells capable of self-renewal and differentiation into all blood lineages, including red blood cells, white blood cells, and platelets. They reside in a specialized microenvironment known as the hematopoietic niche, primarily located in the bone marrow, where they interact with various supporting cells that regulate their function and maintain hematopoietic homeostasis [9].

The maintenance and function of HSCs are influenced by intrinsic and extrinsic factors, including metabolic pathways, signaling molecules, and the cellular composition of the niche. For instance, recent findings indicate that lipid metabolism significantly affects HSC function, challenging the previously held notion that HSCs primarily rely on glycolysis for energy. This shift highlights the importance of understanding metabolic regulation in the context of HSC biology [25].

Moreover, HSCs are not only responsible for steady-state hematopoiesis but also play a pivotal role during stress conditions, such as following injury or infection, when there is an increased demand for blood cell production. Under these circumstances, HSCs can be activated to proliferate and differentiate into various lineages to replenish the blood cell pool [31].

Stem cell transplantation has emerged as a critical therapeutic strategy for treating hematological disorders, including leukemias, lymphomas, and other blood-related diseases. The transplantation of HSCs can restore normal hematopoiesis in patients whose bone marrow is damaged due to disease or chemotherapy. This approach has been shown to improve outcomes in patients with conditions such as GATA2 deficiency, where hematopoietic stem cells are essential for restoring immune function and correcting hematological abnormalities [32].

In summary, HSCs are integral to the formation and maintenance of the blood system, serving both as a source of all blood cell types and as a dynamic responder to physiological needs. The advancements in stem cell transplantation underscore the therapeutic potential of harnessing these cells for treating various hematological disorders, emphasizing the need for continued research into their biology and the mechanisms governing their function [1][5].

6 Advances in Stem Cell Research ​

6.1 Induced Pluripotent Stem Cells (iPSCs) ​

Hematopoiesis, the process of blood cell formation, is fundamentally reliant on hematopoietic stem cells (HSCs). These unique cells possess the capacity for self-renewal and differentiation into all blood lineages, thereby playing a critical role in maintaining blood cell homeostasis throughout an individual's life. The intricate dynamics of hematopoiesis involve both HSC-dependent and HSC-independent mechanisms, particularly during embryonic development and in response to physiological stressors.

HSCs reside within a specialized microenvironment known as the hematopoietic niche, which is crucial for their regulation and function. This niche comprises various supporting cells and extracellular matrix components that provide essential signals to maintain HSC quiescence, promote self-renewal, and guide differentiation into various blood cell types. Factors such as aging and environmental stress can significantly impact the functionality of HSCs, leading to alterations in hematopoiesis and contributing to hematological disorders [2].

Recent studies have highlighted the importance of niche-derived signals in regulating HSC behavior. For instance, aging niches are associated with a decline in HSC function, underscoring the need for continuous interaction between HSCs and their microenvironment to sustain hematopoiesis effectively [31]. Furthermore, the transition of HSCs from the embryonic vascular endothelium to the fetal liver involves complex signaling pathways, including those mediated by microRNAs and integrins, which facilitate the migration and maturation of these cells [11].

Induced pluripotent stem cells (iPSCs) have emerged as a promising tool for advancing our understanding of hematopoiesis. iPSCs can be generated from somatic cells and possess the potential to differentiate into various cell types, including HSCs. This capability allows researchers to model hematopoietic diseases and develop novel therapeutic strategies for conditions such as leukemias and other blood disorders. The ability to derive HSCs from iPSCs offers a unique opportunity to explore the cellular and molecular mechanisms underlying hematopoietic development and the regulation of stem cell fate [21].

In summary, stem cells, particularly HSCs, are pivotal in hematopoiesis, facilitating the continuous replenishment of blood cells throughout life. Their function is intricately regulated by a supportive niche and influenced by both intrinsic and extrinsic factors. The exploration of iPSCs holds significant potential for enhancing our understanding of hematopoietic biology and developing innovative therapies for blood-related diseases.

6.2 Gene Editing Technologies ​

Hematopoietic stem cells (HSCs) play a crucial role in the process of hematopoiesis, which is the formation of blood cells. These stem cells are unique in their ability to self-renew and differentiate into various lineages of blood cells, including red blood cells, white blood cells, and platelets. HSCs reside in a specialized microenvironment, often referred to as the hematopoietic niche, which is primarily located in the bone marrow. This niche provides essential signals that regulate the survival, activation, and quiescence of HSCs, ensuring the continuous production of blood cells throughout an individual's life.

The functionality of HSCs is significantly influenced by various intrinsic and extrinsic factors. For instance, the surrounding niche cells and extracellular matrix components play vital roles in maintaining HSC function. The balance between self-renewal and differentiation is critical; HSCs must retain their capacity to regenerate while also producing differentiated cells to meet the body's demands. This regulation is influenced by metabolic pathways, signaling molecules, and epigenetic factors, which together contribute to the maintenance of hematopoietic homeostasis [9][31].

During development, the specification of HSCs occurs in a stepwise manner, where they transition from progenitor cells in the embryonic environment to fully functional stem cells capable of lifelong hematopoiesis. Recent studies have shown that hematopoietic cells can develop independently of HSCs, particularly during the embryonic period, indicating a more complex landscape of hematopoietic development than previously understood [3].

Furthermore, the role of HSCs extends beyond mere blood cell production; they are also implicated in the body's immune responses and the maintenance of homeostasis. Dysregulation of HSC function can lead to various hematological disorders, including leukemias and other malignancies. For example, genetic alterations affecting HSC behavior can result in abnormal proliferation and differentiation, leading to myeloproliferative diseases [33][34].

Overall, the understanding of HSCs and their role in hematopoiesis is continually evolving, with advancements in gene editing technologies and stem cell research providing new insights into their regulatory mechanisms and potential therapeutic applications. As research progresses, it is anticipated that novel strategies will emerge to harness HSCs for regenerative medicine and the treatment of hematological diseases [21][35].

7 Conclusion ​

This review has elucidated the pivotal role of hematopoietic stem cells (HSCs) in the process of hematopoiesis, emphasizing their unique properties of self-renewal and multipotency. HSCs serve as the foundational precursors for all blood cell types, including red blood cells, white blood cells, and platelets, and their differentiation pathways are tightly regulated by a complex interplay of intrinsic factors, extrinsic signals from the niche, and molecular mechanisms involving transcription factors and signaling pathways. The current understanding of HSC biology has significant implications for both normal physiological processes and the pathophysiology of hematological disorders such as leukemia and aplastic anemia. Advances in stem cell research, including the emergence of induced pluripotent stem cells (iPSCs) and gene editing technologies, hold promise for developing innovative therapeutic strategies. Future research directions should focus on further elucidating the molecular and cellular mechanisms governing HSC function, exploring the impact of the microenvironment on HSC behavior, and leveraging cutting-edge technologies to improve stem cell-based therapies for hematological diseases. The continuous exploration of stem cell biology is essential for enhancing our understanding of hematopoiesis and informing clinical practices.

References ​

  • [1] T M Fliedner. The role of blood stem cells in hematopoietic cell renewal.. Stem cells (Dayton, Ohio)(IF=3.6). 1998. PMID:11012145. DOI: 10.1002/stem.160361.
  • [2] Anand Badhri Narayan;Senthil Kumar Hariom;Ayan Prasad Mukherjee;Deotima Das;Aadhira Nair;Everette Jacob Remington Nelson. 'Nomadic' Hematopoietic Stem Cells Navigate the Embryonic Landscape.. Stem cell reviews and reports(IF=4.2). 2025. PMID:39786676. DOI: 10.1007/s12015-025-10843-6.
  • [3] Tomomasa Yokomizo;Toshio Suda. Development of the hematopoietic system: expanding the concept of hematopoietic stem cell-independent hematopoiesis.. Trends in cell biology(IF=18.1). 2024. PMID:37481335. DOI: 10.1016/j.tcb.2023.06.007.
  • [4] Wilson K Clements;David Traver. Signalling pathways that control vertebrate haematopoietic stem cell specification.. Nature reviews. Immunology(IF=60.9). 2013. PMID:23618830. DOI: 10.1038/nri3443.
  • [5] Jasmin Rettkowski;Nina Cabezas-Wallscheid. Regulation of Hematopoietic Stem Cell Dormancy and Quiescence: Insights into Regeneration and Disease.. Annual review of cell and developmental biology(IF=11.4). 2025. PMID:41034157. DOI: 10.1146/annurev-cellbio-101323-023806.
  • [6] Charles Durand;Elaine Dzierzak. Embryonic beginnings of adult hematopoietic stem cells.. Haematologica(IF=7.9). 2005. PMID:15642676. DOI: .
  • [7] Beatriz Suarez-Alvarez;Ramon M Rodriguez;Mario F Fraga;Carlos López-Larrea. DNA methylation: a promising landscape for immune system-related diseases.. Trends in genetics : TIG(IF=16.3). 2012. PMID:22824525. DOI: .
  • [8] Kilian Sottoriva;Kostandin V Pajcini. Notch Signaling in the Bone Marrow Lymphopoietic Niche.. Frontiers in immunology(IF=5.9). 2021. PMID:34394130. DOI: 10.3389/fimmu.2021.723055.
  • [9] Benjamin J Frisch. The hematopoietic stem cell niche: What's so special about bone?. Bone(IF=3.6). 2019. PMID:29778716. DOI: 10.1016/j.bone.2018.05.017.
  • [10] Claudia Morganti;Massimo Bonora;Keisuke Ito. Metabolism and HSC fate: what NADPH is made for.. Trends in cell biology(IF=18.1). 2025. PMID:39054107. DOI: 10.1016/j.tcb.2024.07.003.
  • [11] Xuan Jiang;John S Hawkins;Jerry Lee;Carlos O Lizama;Frank L Bos;Joan P Zape;Prajakta Ghatpande;Yongbo Peng;Justin Louie;Giorgio Lagna;Ann C Zovein;Akiko Hata. Let-7 microRNA-dependent control of leukotriene signaling regulates the transition of hematopoietic niche in mice.. Nature communications(IF=15.7). 2017. PMID:28743859. DOI: 10.1038/s41467-017-00137-y.
  • [12] Helmut Greim;Debra A Kaden;Richard A Larson;Christine M Palermo;Jerry M Rice;David Ross;Robert Snyder. The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment.. Annals of the New York Academy of Sciences(IF=4.8). 2014. PMID:24495159. DOI: 10.1111/nyas.12362.
  • [13] Asja Praetor;Jacqueline M McBride;Henry Chiu;Linda Rangell;Lorena Cabote;Wyne P Lee;James Cupp;Dimitry M Danilenko;Sherman Fong. Genetic deletion of JAM-C reveals a role in myeloid progenitor generation.. Blood(IF=23.1). 2009. PMID:19109565. DOI: 10.1182/blood-2008-06-159574.
  • [14] Kipp Weiskopf;Peter J Schnorr;Wendy W Pang;Mark P Chao;Akanksha Chhabra;Jun Seita;Mingye Feng;Irving L Weissman. Myeloid Cell Origins, Differentiation, and Clinical Implications.. Microbiology spectrum(IF=3.8). 2016. PMID:27763252. DOI: 10.1128/microbiolspec.MCHD-0031-2016.
  • [15] Anupriya Agarwal;William J Bolosky;David B Wilson;Christopher A Eide;Susan B Olson;Guang Fan;Brian J Druker. Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2019. PMID:31754026. DOI: 10.1073/pnas.1904091116.
  • [16] Nikki R Kong;Matthew Davis;Li Chai;Astar Winoto;Robert Tjian. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.. PLoS genetics(IF=3.7). 2016. PMID:26900922. DOI: 10.1371/journal.pgen.1005845.
  • [17] Shicheng Sun;Kevin Wijanarko;Oniko Liani;Kathleen Strumila;Elizabeth S Ng;Andrew G Elefanty;Edouard G Stanley. Lymphoid cell development from fetal hematopoietic progenitors and human pluripotent stem cells.. Immunological reviews(IF=8.3). 2023. PMID:36939073. DOI: 10.1111/imr.13197.
  • [18] Motonari Kondo. Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors.. Immunological reviews(IF=8.3). 2010. PMID:20969583. DOI: 10.1111/j.1600-065X.2010.00963.x.
  • [19] Rasoul Godini;Jingjing Yan;Michaël Chopin. Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions.. Frontiers in immunology(IF=5.9). 2025. PMID:40510370. DOI: 10.3389/fimmu.2025.1544483.
  • [20] Christian Kosan;Maren Godmann. Genetic and Epigenetic Mechanisms That Maintain Hematopoietic Stem Cell Function.. Stem cells international(IF=3.3). 2016. PMID:26798358. DOI: 10.1155/2016/5178965.
  • [21] Akhilesh Kumar;Saritha S D'Souza;Abir S Thakur. Understanding the Journey of Human Hematopoietic Stem Cell Development.. Stem cells international(IF=3.3). 2019. PMID:31198425. DOI: 10.1155/2019/2141475.
  • [22] Stuart H Orkin;Leonard I Zon. Hematopoiesis: an evolving paradigm for stem cell biology.. Cell(IF=42.5). 2008. PMID:18295580. DOI: 10.1016/j.cell.2008.01.025.
  • [23] Cecilia Pessoa Rodrigues;Maria Shvedunova;Asifa Akhtar. Epigenetic Regulators as the Gatekeepers of Hematopoiesis.. Trends in genetics : TIG(IF=16.3). 2020. PMID:34756331. DOI: 10.1016/j.tig.2020.09.015.
  • [24] Fabíola Silva Alves-Hanna;Juniel Assis Crespo-Neto;Glenda Menezes Nogueira;Daniele Sá Pereira;Amanda Barros Lima;Thaís Lohana Pereira Ribeiro;Vitória Giovanna Rodrigues Santos;Joey Ramone Ferreira Fonseca;Fábio Magalhães-Gama;Aya Sadahiro;Allyson Guimarães Costa. Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?. Journal of immunology research(IF=3.6). 2023. PMID:37577033. DOI: 10.1155/2023/5584492.
  • [25] Man K S Lee;Annas Al-Sharea;Dragana Dragoljevic;Andrew J Murphy. Hand of FATe: lipid metabolism in hematopoietic stem cells.. Current opinion in lipidology(IF=4.6). 2018. PMID:29528857. DOI: 10.1097/MOL.0000000000000500.
  • [26] Rebecca E Ling;Joe W Cross;Anindita Roy. Aberrant stem cell and developmental programs in pediatric leukemia.. Frontiers in cell and developmental biology(IF=4.3). 2024. PMID:38601080. DOI: 10.3389/fcell.2024.1372899.
  • [27] Steven W Lane;D Gary Gilliland. Leukemia stem cells.. Seminars in cancer biology(IF=15.7). 2010. PMID:20026405. DOI: 10.1016/j.semcancer.2009.12.001.
  • [28] C Riether;C M Schürch;A F Ochsenbein. Regulation of hematopoietic and leukemic stem cells by the immune system.. Cell death and differentiation(IF=15.4). 2015. PMID:24992931. DOI: 10.1038/cdd.2014.89.
  • [29] Stephen S Chung;Wenhuo Hu;Christopher Y Park. The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function.. Therapeutic advances in hematology(IF=3.1). 2011. PMID:23556099. DOI: 10.1177/2040620711410772.
  • [30] Shirin Azizidoost;Ava Nasrolahi;Mohadeseh Sheykhi-Sabzehpoush;Amir Anbiyaiee;Seyed Esmaeil Khoshnam;Maryam Farzaneh;Shahab Uddin. Signaling pathways governing the behaviors of leukemia stem cells.. Genes & diseases(IF=9.4). 2024. PMID:37692500. DOI: 10.1016/j.gendis.2023.01.008.
  • [31] Xinyu Tang;Zhenzhen Wang;Jingyi Wang;Siyuan Cui;Ruirong Xu;Yan Wang. Functions and regulatory mechanisms of resting hematopoietic stem cells: a promising targeted therapeutic strategy.. Stem cell research & therapy(IF=7.3). 2023. PMID:37038215. DOI: 10.1186/s13287-023-03316-5.
  • [32] Beatriz E Marciano;Kenneth N Olivier;Les R Folio;Christa S Zerbe;Amy P Hsu;Alexandra F Freeman;Armando C Filie;Michael A Spinner;Lauren A Sanchez;Jana P Lovell;Mark Parta;Jennifer M Cuellar-Rodriguez;Dennis D Hickstein;Steven M Holland. Pulmonary Manifestations of GATA2 Deficiency.. Chest(IF=8.6). 2021. PMID:34089740. DOI: 10.1016/j.chest.2021.05.046.
  • [33] Sofie Singbrant;Meaghan Wall;Jennifer Moody;Göran Karlsson;Alistair M Chalk;Brian Liddicoat;Megan R Russell;Carl R Walkley;Stefan Karlsson. The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative disease.. Haematologica(IF=7.9). 2014. PMID:24415629. DOI: 10.3324/haematol.2013.093971.
  • [34] T Velasco-Hernandez;D Tornero;J Cammenga. Loss of HIF-1α accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia.. Leukemia(IF=13.4). 2015. PMID:26104662. DOI: 10.1038/leu.2015.156.
  • [35] Marta Lionetti;Margherita Scopetti;Antonio Matera;Akihiro Maeda;Alessio Marella;Francesca Lazzaroni;Giancarlo Castellano;Sonia Fabris;Stefania Pioggia;Silvia Lonati;Alfredo Marchetti;Alessandra Cattaneo;Marta Tornese;Antonino Neri;Claudia Leoni;Loredana Pettine;Valentina Traini;Ilaria Silvestris;Marzia Barbieri;Giuseppina Fabbiano;Domenica Ronchetti;Elisa Taiana;Claudio De Magistris;Matteo C Da Vià;Francesco Passamonti;Niccolò Bolli. Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.. Blood(IF=23.1). 2025. PMID:40112284. DOI: 10.1182/blood.2024026236.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Hematopoietic Stem Cells · Hematopoiesis · Differentiation Pathways · Hematological Disorders · Gene Editing

© 2025 MaltSci